These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34478591)

  • 1. Autoimmune hepatitis triggered by COVID-19: A report of two cases.
    Kabaçam G; Wahlin S; Efe C
    Liver Int; 2021 Oct; 41(10):2527-2528. PubMed ID: 34478591
    [No Abstract]   [Full Text] [Related]  

  • 2. Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19?
    Terziroli Beretta-Piccoli B; Lleo A
    Liver Int; 2022 Feb; 42(2):274-276. PubMed ID: 35092335
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmune hepatitis triggered by COVID-19.
    Montón Rodríguez C; Navarro Cortés P; Lluch García P; Mínguez Pérez M
    Rev Esp Enferm Dig; 2022 Jan; 114(1):64-65. PubMed ID: 34015933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with autoimmune liver disease during COVID-19 pandemic.
    Lleo A; Invernizzi P; Lohse AW; Aghemo A; Carbone M
    J Hepatol; 2020 Aug; 73(2):453-455. PubMed ID: 32283134
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune hepatitis triggered by COVID-19.
    Hong JK; Chopra S; Kahn JA; Kim B; Khemichian S
    Intern Med J; 2021 Jul; 51(7):1182-1183. PubMed ID: 34278694
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality.
    Rocco A; Sgamato C; Compare D; Nardone G
    J Hepatol; 2021 Sep; 75(3):728-729. PubMed ID: 34116081
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis.
    Kirchner T; Jaeckel E; Falk CS; Eiz-Vesper B; Taubert R
    J Hepatol; 2021 Dec; 75(6):1506-1509. PubMed ID: 34284030
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe autoimmune hepatitis following recovery from COVID-19: a novel mode of liver injury triggered by SARS-COV-2?
    Folman A; Said-Ahmad H; Mari A; Saadi T; Veitsman E; Yaccob A
    Minerva Gastroenterol (Torino); 2022 Sep; 68(3):334-336. PubMed ID: 35001607
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use.
    Ng AC
    Hepatol Commun; 2021 Oct; 5(10):1801-1802. PubMed ID: 34222740
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to: "Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"".
    Bril F; Fettig DM
    J Hepatol; 2021 Oct; 75(4):996-997. PubMed ID: 34146650
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter to the Editor: Reply to Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use.
    Efe C; Wahlin S
    Hepatol Commun; 2022 Nov; 6(11):3272. PubMed ID: 34558846
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune Hepatitis Associated with COVID-19 Infection - A Diagnostic and Therapeutic Dilemma.
    Rajendiran G; Cowman B; Erickson K; Oliver T; Manatsathit W
    S D Med; 2020 Nov; 73(11):528-532. PubMed ID: 33684272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?".
    Capecchi PL; Lazzerini PE; Brillanti S
    J Hepatol; 2021 Oct; 75(4):994-995. PubMed ID: 33964372
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: One or even several swallows do not make a summer.
    Bril F
    J Hepatol; 2021 Nov; 75(5):1256-1257. PubMed ID: 34384822
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of immunosuppression in autoimmune hepatitis: A current literature review.
    Cropley A; Weltman M
    Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine.
    de Boer NK; van Nieuwkerk CM; Aparicio Pages MN; de Boer SY; Derijks LJ; Mulder CJ
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):457-61. PubMed ID: 15756101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.
    Andries S; Casamayou L; Sempoux C; Burlet M; Reding R; Bernard Otte J; Buts JP; Sokal E
    Transplantation; 2001 Jul; 72(2):267-72. PubMed ID: 11477351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association?
    Tan CK; Wong YJ; Wang LM; Ang TL; Kumar R
    J Hepatol; 2021 Nov; 75(5):1250-1252. PubMed ID: 34153398
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of pharmacotherapy for autoimmune hepatitis.
    Heneghan MA; Al-Chalabi T; McFarlane IG
    Expert Opin Pharmacother; 2006 Feb; 7(2):145-56. PubMed ID: 16433580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A typical autoimmune hepatitis (AIH) case following Covid-19 mRNA vaccination. More than a coincidence?
    Goulas A; Kafiri G; Kranidioti H; Manolakopoulos S
    Liver Int; 2022 Jan; 42(1):254-255. PubMed ID: 34724315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.